A Study of the Drug Interactions Between a Hormonal Emergency Contraception and an HIV Medication

• Status: Completed
• Trial end date: 2008-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to determine if blood levels of the hormonal emergency contraceptive agent, Plan B, are altered by concomitant use with the HIV medication, efavirenz.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Colorado, Denver
• Collaborators: Bristol-Myers Squibb; The Miriam Hospital; University of Washington
• Treatments: Efavirenz; Levonorgestrel

Criteria

Inclusion Criteria:

• Healthy, HIV-1 seronegative women of child-bearing age.

Exclusion Criteria:

• Current use of hormonal contraception

• Pregnancy/Breast Feeding

• Post-menopausal status

• Obesity

• Hepatitis B or C

• Psychiatric illness

• Active Substance Abuse